Neuroblastoma inhibition by targeting BET protein overexpression is a novel research finding, as previous studies revealed that several scientists tried to find a BET protein inhibitor using a combination of two drugs, some of which used recombinant protein inhibitors using a combination of two drugs with some of them using recombinant protein [38,39]. The gene discussed is DNER; the disease is neuroblastoma.